Abbreviations 4E-BP1: Eukaryotic translation initiation factor 4E-binding protein-1 6W: Six-minute walk test AEs: Adverse events BMI: Body mass index Comp: Composite endpoint DXA: Dual-energy X-ray absorptiometry ITT: Intent-to-treat LS: Lower strength MM: Muscle mass mTOR: Mammalian target of rapamycin MuRF1: Muscle RING-finger protein-1 NNHPD: Natural and non-prescription health products directorate NSAID: Non-steroidal anti-inflammatory drug PP: Per-protocol QoL: Quality of life S6K: p70-S6 kinase UPS: Ubiquitinproteasome system US: Upper strength References Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan Van KG, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De MC, Donini L, Harris T, Kannt A, Keime GF, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M
It should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in those with multiple endocrine neoplasia syndrome type 2 (MEN 2)
Stopping is not benign, monitoring afterward is essential
Heres how it works: Tesamorelin activates GHRH receptors
